Hi there!
We track 52,000+ AI startups and surface hidden job opportunities that never appear on LinkedIn. Tell us what you're looking for, our AI agent does the searching. It's free and you sign up using Google. Go explore!
Ligence
Cardiac ultrasound is a safe and inexpensive test for monitoring and preventing heart disease. Manual work (e.g. measuring, writing report) takes 50-85% of test time. We make cardiac ultrasound more…
Ligence
Cardiac ultrasound is a safe and inexpensive test for monitoring and preventing heart disease. Manual work (e.g. measuring, writing report) takes 50-85% of test time. We make cardiac ultrasound more…
TL;DR
Company: Ligence — Lithuanian deep-tech medical software company (UAB Ligence)
Product: Ligence Heart — web-based AI echocardiography analysis and reporting platform
Regulatory status: FDA 510(k) cleared and CE-marked
Headcount: About 29 employees
Funding: Seed round ~€3M (led by Simpact Ventures; includes EIC convertible loan)
Company Overview
Problem Domain
Medical imaging / cardiac ultrasound automation
Industry
Software Development
Funding Track Record
≈€3M
Round includes a convertible loan from the European Innovation Council (EIC) Fund; reported participation from multiple investors ( Crunchbase lists 11 investors).
Investor Signal
“Seed round led by Simpact Ventures with participation including the European Innovation Council (EIC) Fund”
Founders
What we do
Join the Team
Startup jobs. A lot of them.
Your next opportunity is in here somewhere. Sign up to explore 52,000+ startups and their open roles. No spam. No gamification. Just jobs.
52,000+
Startups
66,000+
Open Roles
1,500+
New This Week
Related Companies
| Company |
|---|
 |
 |
 |
 |
 |